A second phase of this study will include biobank data from some 1,000 additional patients in Europe and the U.S, and it should be complete in the coming months, Diadem stated in the release. The test ...

Alzheimer’s disease (AD) is associated with a gradual decline in memory and mental ability, due to the accumulation and spread of damage in the brain. It is an irreversible condition, with symptoms ...

“In the care home, I really wanted Jelly Drops to tackle dehydration and also to be really fun and engaging and sort of a social tool in the care home as well,” Hornby said in a video interview with ...

There were also incidents when my mother spoke harshly to a stranger, and I gently told her that she needed to remember to be kind. She always accepted that information and reverted to her core ...

In earlier work, the team showed that aluminum clustered in the same spots as amyloid-beta in the brain of an Alzheimer’s patient. Other studies have shown that amyloid-beta binds aluminum, which ...

Namenda (memantine) is an approved medicine for the treatment of moderate to severe Alzheimer’s disease. When nerve cells are damaged, it is believed that some start to release excess glutamate, ...

With this approval, Aduhelm becomes the first disease-modifying therapy for Alzheimer’s, and the first such therapy to come under FDA review. Disease-modifying therapies are those capable of slowing ...

Mice with low levels of L-serine and D-serine had impaired spatial memory, which is the type of memory that allows us to remember where things are located, both on a short-term and long-term basis, as ...

Researchers conducted a randomized, double-blind, placebo-controlled clinical trial approved by the local ethical committee. The study enrolled 26 healthy participants whose short-term memory and ...

The Phase 1b portion was a one-month ascending dose phase to assess its safety, tolerability, and pharmacological properties. In the Phase 2 efficacy portion, participants were randomly assigned ...

Patients with Alzheimer’s disease (AD) experience a slow progressive decline in memory and cognitive ability, among other symptoms, due to the spread of damage in the brain. Generally, the disease is ...

Co-founder and managing art director Tavé Drake described Mirador as a “digital and print publication for the enjoyment of people experiencing brain change from Alzheimer’s, dementia-related ...